New Additions to Drugs.com for 2025
The following 12 drugs were added to the Drugs.com database in 2025.
Nuvaxovid
Sep 3, 2025 - Nuvaxovid 2025-2026 formula is a protein-based COVID-19 vaccine designed to protect against COVID-19 disease caused by currently circulating JN.1 lineage strains of SARS-CoV-2.
mNEXSPIKE
Sep 2, 2025 - mNEXSPIKE is a low-dose 2025-2026 COVID-19 vaccine from Moderna targeting the currently circulating LP.8.1 variant of SARS-CoV-2 designed to protect against COVID-19 infection.
Cyklx
Aug 18, 2025 - Cyklx is an amide local anesthetic administered by a healthcare provider to anesthetize the surface of the eye before eye procedures or eye injections in adults and children.
Papzimeos
Aug 18, 2025 - Papzimeos is a first-of-kind, non-replicating adenoviral vector-based immunotherapy used to treat recurrent respiratory papillomatosis (RRP) in adults.
Brinsupri
Aug 13, 2025 - Brinsupri is an oral DPP1 inhibitor used to treat non-cystic fibrosis bronchiectasis in adults and children 12 years and older.
Zegfrovy
Jul 9, 2025 - Zegfrovy is an oral kinase inhibitor used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.
Lynozyfic
Jul 2, 2025 - Lynozyfic is a BCMA-directed CD3 T-cell engager used to treat relapsed or refractory multiple myeloma in adults who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti‑CD38 monoclonal antibody.
Arynta
Jun 24, 2025 - Arynta is an oral solution containing lisdexamfetamine used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children 6 years of age and older and Binge Eating Disorder (BED) in adults.
Harliku
Jun 24, 2025 - Harliku is a hydroxyphenyl-pyruvate dioxygenase inhibitor used to reduce levels of homogentisic acid in the urine of adults with alkaptonuria (AKU), a very rare genetic metabolic disorder.
Ibtrozi
Jun 11, 2025 - Ibtrozi is a kinase inhibitor used to treat locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) in adults.
Miudella
Apr 2, 2025 - Miudella is a hormone-free, low-dose, copper-releasing intrauterine system (IUS) designed for pregnancy prevention for up to 3 years.
Opdivo Qvantig
Jan 1, 2025 - Opdivo Qvantig is a new formulation of Opdivo that contains hyaluronidase that allows it to be given subcutaneously (under the skin) and over 3 to 5 minutes. Opdivo Qvantig is used to treat adults with certain types of melanoma, non-small cell lung cancer, renal cell carcinoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, gastric cancer, or gastroesophageal junction cancer.